Actively Recruiting
Parasternal Blockade and Serum Lactate in Cardiac Surgery
Led by Instituto Mexicano del Seguro Social · Updated on 2024-07-24
86
Participants Needed
1
Research Sites
52 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Serum lactate level is a key indicator of tissue perfusion. Parasternal blockade is associated with reduced postoperative inflammatory response by inhibiting stress response, leading to better outcomes. Elevated lactate levels help identify patients at risk of postoperative morbidity and mortality. This analytical cross-sectional study evaluated the association between parasternal blockade and serum lactate levels in patients undergoing elective cardiac surgery in 2022 at Specialty Hospital CMNO. Patients with and without parasternal block were compared for changes in serum lactate levels during and after anesthesia within the first 24 hours.
CONDITIONS
Official Title
Parasternal Blockade and Serum Lactate in Cardiac Surgery
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult patients older than 18 years
- Either sex
- ASA II-III
- Patients who underwent cardiac surgery with median sternotomy and use of cardiopulmonary bypass.
You will not qualify if you...
- Patients with pre-existing conditions that could independently affect serum lactate levels.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Centro Médico Nacional de Occidente
Guadalajara, Jalisco, Mexico, 44329
Actively Recruiting
Research Team
A
Alejandro Gonzalez, 3
CONTACT
C
Clotilde Fuentes, 1
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here